Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic Products

Automated detection of impurities is in demand for evaluating the quality and safety of human cell-processed therapeutic products in regenerative medicine. Deep learning (DL) is a powerful method for classifying and recognizing images in cell biology, diagnostic medicine, and other fields because it...

Full description

Bibliographic Details
Main Authors: Yasunari Matsuzaka, Shinji Kusakawa, Yoshihiro Uesawa, Yoji Sato, Mitsutoshi Satoh
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/11/20/9755
_version_ 1797515329619886080
author Yasunari Matsuzaka
Shinji Kusakawa
Yoshihiro Uesawa
Yoji Sato
Mitsutoshi Satoh
author_facet Yasunari Matsuzaka
Shinji Kusakawa
Yoshihiro Uesawa
Yoji Sato
Mitsutoshi Satoh
author_sort Yasunari Matsuzaka
collection DOAJ
description Automated detection of impurities is in demand for evaluating the quality and safety of human cell-processed therapeutic products in regenerative medicine. Deep learning (DL) is a powerful method for classifying and recognizing images in cell biology, diagnostic medicine, and other fields because it automatically extracts the features from complex cell morphologies. In the present study, we construct prediction models that recognize cancer-cell contamination in continuous long-term (four-day) cell cultures. After dividing the whole dataset into Early- and Late-stage cell images, we found that Late-stage images improved the DL performance. The performance was further improved by optimizing the DL hyperparameters (batch size and learning rate). These findings are first report for the implement of DL-based systems in disease cell-type classification of human cell-processed therapeutic products (hCTPs), that are expected to enable the rapid, automatic classification of induced pluripotent stem cells and other cell treatments for life-threatening or chronic diseases.
first_indexed 2024-03-10T06:43:58Z
format Article
id doaj.art-025766a86f5848ea9aed766f4aae37a9
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-10T06:43:58Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-025766a86f5848ea9aed766f4aae37a92023-11-22T17:23:51ZengMDPI AGApplied Sciences2076-34172021-10-011120975510.3390/app11209755Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic ProductsYasunari Matsuzaka0Shinji Kusakawa1Yoshihiro Uesawa2Yoji Sato3Mitsutoshi Satoh4Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose 204-8588, Tokyo, JapanDivision of Cell-Based Therapeutic Producers, National Institute of Health Sciences, Kawasaki 201-9501, Kanagawa, JapanDepartment of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose 204-8588, Tokyo, JapanDivision of Cell-Based Therapeutic Producers, National Institute of Health Sciences, Kawasaki 201-9501, Kanagawa, JapanDepartment of Toxicology and Pharmacology, Faculty of Pharmaceutical Sciences, Meiji Pharmaceutical University, Kiyose 204-8588, Tokyo, JapanAutomated detection of impurities is in demand for evaluating the quality and safety of human cell-processed therapeutic products in regenerative medicine. Deep learning (DL) is a powerful method for classifying and recognizing images in cell biology, diagnostic medicine, and other fields because it automatically extracts the features from complex cell morphologies. In the present study, we construct prediction models that recognize cancer-cell contamination in continuous long-term (four-day) cell cultures. After dividing the whole dataset into Early- and Late-stage cell images, we found that Late-stage images improved the DL performance. The performance was further improved by optimizing the DL hyperparameters (batch size and learning rate). These findings are first report for the implement of DL-based systems in disease cell-type classification of human cell-processed therapeutic products (hCTPs), that are expected to enable the rapid, automatic classification of induced pluripotent stem cells and other cell treatments for life-threatening or chronic diseases.https://www.mdpi.com/2076-3417/11/20/9755human cell-processed therapeutic productsdeep learningconvolutional neural networkshyperparametersimage classification
spellingShingle Yasunari Matsuzaka
Shinji Kusakawa
Yoshihiro Uesawa
Yoji Sato
Mitsutoshi Satoh
Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic Products
Applied Sciences
human cell-processed therapeutic products
deep learning
convolutional neural networks
hyperparameters
image classification
title Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic Products
title_full Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic Products
title_fullStr Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic Products
title_full_unstemmed Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic Products
title_short Deep Learning-Based In Vitro Detection Method for Cellular Impurities in Human Cell-Processed Therapeutic Products
title_sort deep learning based in vitro detection method for cellular impurities in human cell processed therapeutic products
topic human cell-processed therapeutic products
deep learning
convolutional neural networks
hyperparameters
image classification
url https://www.mdpi.com/2076-3417/11/20/9755
work_keys_str_mv AT yasunarimatsuzaka deeplearningbasedinvitrodetectionmethodforcellularimpuritiesinhumancellprocessedtherapeuticproducts
AT shinjikusakawa deeplearningbasedinvitrodetectionmethodforcellularimpuritiesinhumancellprocessedtherapeuticproducts
AT yoshihirouesawa deeplearningbasedinvitrodetectionmethodforcellularimpuritiesinhumancellprocessedtherapeuticproducts
AT yojisato deeplearningbasedinvitrodetectionmethodforcellularimpuritiesinhumancellprocessedtherapeuticproducts
AT mitsutoshisatoh deeplearningbasedinvitrodetectionmethodforcellularimpuritiesinhumancellprocessedtherapeuticproducts